KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
61 hedge funds and large institutions have $566M invested in Kalaris Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+60
Holders Change %
+6,000%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$4K
Top Buyers
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Morgan Stanley
New York
| $120K | +$120K | +190 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $101K | +$101K | +159 | New |
|
53
Legal & General Group
London,
United Kingdom
| $55K | +$55K | +88 | New |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| $42K | +$42K | +66 | New |
|
55
UBS Group
Zurich,
Switzerland
| $28K | +$28K | +44 | New |
|
56
Bank of America
Charlotte,
North Carolina
| $27K | +$27K | +43 | New |
|
57
Bank of Montreal
Toronto,
Ontario, Canada
| $25K | +$25K | +36 | New |
|
58
Citigroup
New York
| $24K | +$24K | +37 | New |
|
|
CG
59
Cutler Group
San Francisco,
California
| $13K | +$13K | +22 | New |
|
60
Simplex Trading
Chicago,
Illinois
| $3K | +$3K | +5 | New |
|